Gallafent, Alison competitive analysis

Explore patent oppositions filed by Gallafent, Alison against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
1-Aryl-3-Aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency ThereofESTEVE PHARMACEUTICALSJul 1, 2015
Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineEURO CELTIQUEJan 24, 2014

Latest PTAB cases involving Gallafent, Alison

Discover the latest PTAB cases involving Gallafent, Alison, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gallafent, Alison with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GALLAFENT, ALISON2 - - -
ESTEVE PHARMACEUTICALS - 4 - -
EURO CELTIQUE - 73 - -
LABORATORIOS DEL DR ESTEVE - 4 - -